Source: Breathe, 15 (3) e122; 10.1183/20734735.0183-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Daisy J.A. Janssen, Marieke H.J. van den Beuken-van Everdingen, Cornelia A. Verberkt, Jacques P.H.M. Creemers, Emiel F.M. Wouters. Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness. Breathe, 15 (3) e122; 10.1183/20734735.0183-2019

Member's Comments

No comment yet.

Related content which might interest you: Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017 Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 The prevelance of chronic nasal symptoms in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 264s Year: 2002 Overdiagnosis of COPD and asthma among elderly with chronic dyspnea Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021 Efficacy of inhalation from different powder inhalators in COPD patiens with chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 High-flow nasal cannulae therapy or NIV in patients with exacerbations of chronic obstructive pulmonary disease? Source: Sleep and Breathing Conference 2021 Year: 2021 Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Dyspnea and hypoxemia in COPD and CHF patients is more severe and prolonged after acetate hemodialysis Source: Annual Congress 2008 - Exercise: system responses Year: 2008 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Budesonide/formoterol in a single inhaler reduces severe and mild exacerbations in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 242s Year: 2002 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Chronic cough in COPD Source: Annual Congress 2003 - New pathophysiological aspects in COPD Year: 2003 Roflumilast with long-acting ?2-agonists for COPD: influence of exacerbation history Source: Eur Respir J 2011; 38: 553-560 Year: 2011 Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009 A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 217-224 Year: 2002 Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Effect of erdosteine on airflow obstruction and symptom recovery in severe COPD exacerbations Source: Annual Congress 2011 - COPD management Year: 2011